CliniSys acquires HORIZON Lab Systems and combines with Sunque... - 19 January 2022 01:00

TUCSON, Arizona, Jan. 18, 2022 /PRNewswire-AsiaNet/-- - Combined group to enable better public health outcomes through innovation in diagnostics and laboratory informatics technology CliniSys is announcing the recent acquisition of HORIZON Lab Systems and the combination with Sunquest Informatio...

  Dermaliq Therapeutics Signs USD 15 Million Series A Round to A... - 18 January 2022 20:00

WILMINGTON, Del., Jan. 18, 2022 /PRNewswire-AsiaNet/ -- - Dermaliq Therapeutics, Inc. is an independent private pharmaceutical company emerged from Novaliq - Spin-off to unlock value in the space of medical dermatology by using Novaliq's transformative technology outside eye care - 3E Bioventures...

  Menarini Diagnostics CoronaMeltVAR Real-Time PCR kit simultane... - 18 January 2022 01:40

FLORENCE, Italy, Jan. 17, 2022 /PRNewswire-AsiaNet/ -- The new Omicron variant is spreading rapidly causing an increase in infections at unprecedented speed. On November 28th, WHO officially recommended laboratories to use Real Time PCR detection kits capable of identifying putative Omicron variant in...

  MicroPort CRM Receives Approval in Japan for Alizea Bluetooth ... - 17 January 2022 16:09

CLAMART, France, Jan. 17, 2022 /PRNewswire-Asianet/ -- MicroPort CRM, a pioneering company in the field of Cardiac Rhythm Management, headquartered in France, recently received PMDA Japanese regulation agency approval for its latest range of implantable pacemakers, Alizea. The devices are equipped wit...

  LumiraDx Lab Analysis Confirms its COVID-19 Antigen Test Detec... - 14 January 2022 22:18

LONDON, Jan. 14, 2022 /PRNewswire-AsiaNet/ -- --Results from ongoing testing and monitoring of COVID-19 variants shows the rapid microfluidic test detects Omicron at a comparable sensitivity to other variants LumiraDx (Nasdaq: LMDX), a next-generation point of care diagnostics company, to...

  PostEra Closes $24M in New Financing to Advance Drug Discovery - 12 January 2022 01:00

BOSTON, Jan. 11, 2022 /PRNewswire-AsiaNet/ -- PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced $24M in equity financing to accelerate medicinal chemistry and bring new cures to patients. Logo - https://mma.prnewswire.com/medi...

  Cambrex Celebrates its 40th Anniversary while Investing over $... - 12 January 2022 00:30

EAST RUTHERFORD, N.J., Jan. 11, 2022 /PRNewswire-AsiaNet/ -- Cambrex recently celebrated the 40th anniversary of its founding in 1981. Following forty years of growth and transformation into a leading global contract development and manufacturing organization (CDMO), Cambrex continues its commitment to lead...

  Gift of Life Donor Program Breaks National Records in Saving L... - 12 January 2022 00:05

PHILADELPHIA, Jan. 11, 2022 /PRNewswire-AsiaNet/ -- -- New CEO Richard Hasz Salutes Region – the Most Generous in the Nation for 14 Consecutive Years – and Team of "Heroes" for Extraordinary Commitment Gift of Life Donor Program ( https://c212.net/c/link/?t=0&l=en&o=3408741-1&h=3867576698&u=http...

  Clario and XingImaging expand partnership to deliver PET imagi... - 12 January 2022 00:00

BEIJING and PRINCETON, N.J., Jan. 11, 2022 /PRNewswire-AsiaNet/ -- Clario, a technology company that delivers the leading endpoint technology solutions for clinical trials, and XingImaging, a radiopharmaceutical production and positron emission tomography (PET) acquisition company, have expanded their partnership...

  Virtue Diagnostics closes $100 million Series B Funding - 06 January 2022 14:38

SHANGHAI, Jan. 6, 2022 /PRNewswire-AsiaNet/ -- Virtue Diagnostics, an innovative IVD company, has just announced closing US$100 million in Series B funding. Virtue Diagnostics, founded in 2019, is focused on clinical tests for China and emerging markets. Sequoia China and Morningside Ventures ...